IP Library Granted Patent US 7,632,933
Granted Patent B2
US 7,632,933 · App. 11/701,912 · Granted Dec 15, 2009

Corticotropin releasing factor 2 receptor agonists

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,632,933
App. No.
11/701,912
Granted
Dec 15, 2009
Kind
B2
Abstract

Isolated corticotropin releasing factor derivatives, and nucleic acids encoding the same, are effective for treating corticotropin releasing factor 2 receptor modulated disorders such as muscular dystrophy.

Claims (36)

1. An isolated nucleic acid encoding for a non-native peptide, wherein the non-native peptide comprises the sequence

(SEQ ID NO: 531)

X 1 X 2 PSLSIDX 9 PX 11 X 12 LLRTLLELEKTQSQRERAEQNAX 35 IFAX 39

V;

wherein:

X 1 is selected from nil and D;

X 2 is selected from nil and N;

X 9 is selected from L and V;

X 11 is selected from L and F;

X 12 is selected from L, F and Y;

X 35 is selected from R, H and Q; and

X 39 is selected from H and R;

and variants thereof having at least 95% sequence identity to said peptide.

2. An isolated nucleic acid according to claim 1 , wherein X 1 X 2 are selected from the group consisting of DN, and nil nil.

3. An isolated nucleic acid according to claim 1 , wherein X 11 X 12 are selected from the group consisting of LL, LF, FF, and LY.

4. An isolated nucleic acid according to claim 2 , wherein X 11 X 12 are selected from the group consisting of LL, LF, FF, and LY.

5. An isolated nucleic acid according to claim 1 , wherein X 9 is L.

6. An isolated nucleic acid according to claim 1 , wherein X 35 is R.

7. An isolated nucleic acid according to claim 1 , wherein X 39 is R.

8. An isolated nucleic acid according to claim 1 , wherein the non-native peptide comprises a sequence selected from the group consisting of SEQ ID NO: 324, 328, 331, 333, 334, 341, 384, 385, 386, and 387.

9. An isolated nucleic acid according to claim 1 , wherein the variant has at least 97% sequence identity to said non-native peptide.

10. An isolated nucleic acid encoding for a non-native peptide, wherein the non-native peptide comprises the sequence of SEQ ID NO: 341, and variants thereof having at least 95% sequence identity to said non-native peptide.

11. An isolated nucleic acid according to claim 10 , wherein the variant has at least 97% sequence identity to said non-native peptide.

12. An isolated nucleic acid encoding for a non-native peptide, wherein the non-native peptide comprises the sequence of SEQ ID NO: 341.

13. An isolated nucleic acid encoding for a non-native peptide, wherein the non-native peptide comprises the sequence:

(SEQ ID NO: 531)

X 1 X 2 PSLSIDX 9 PX 11 X 12 LLRTLLELEKTQSQRERAEQNAX 35 IFAX 39

V;

wherein:

X 1 is selected from nil and D;

X 2 is selected from nil and N;

X 9 is selected from L and V;

X 11 is selected from L, and F;

X 12 is selected from L, F, and Y;

X 35 is selected from R, H, and Q; and

X 39 is selected from H and R.

Assignments (7)
CORRECTIVE ASSIGNMENT TO CORRECT THE US PATENT NO. 8,050,873 PREVIOUSLY RECORDED ON REEL 040183 FRAME 0129. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Feb 22, 2018
From: WARNER CHILCOTT COMPANY, LLC
To: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
Reel/Frame 045417/0593 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2016
From: WARNER CHILCOTT COMPANY, LLC
To: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
Reel/Frame 040183/0129 →
RELEASE OF SECURITY INTEREST Recorded Oct 31, 2013
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: WARNER CHILCOTT COMPANY, LLC
Reel/Frame 031531/0538 →
SECURITY AGREEMENT Recorded Mar 30, 2011
From: WARNER CHILCOTT COMPANY LLC
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 026064/0607 →
RELEASE - REEL 023456, FRAME 0052 Recorded Mar 29, 2011
From: CREDIT SUISSSE AG, CAYMAN ISLANDS BRANCH, AS ADMINISTRATIVE AGENT
To: WARNER CHILCOTT COMPANY LLC
Reel/Frame 026042/0046 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2010
From: PROCTER & GAMBLE COMPANY, THE
To: WARNER CHILCOTT COMPANY, LLC
Reel/Frame 023796/0417 →
SECURITY AGREEMENT Recorded Nov 2, 2009
From: WARNER CHILCOTT COMPANY, LLC
To: CREDIT SUISSE, CAYMAN ISLANDS BRANCH, AS ADMINISTRATIVE AGENT
Reel/Frame 023456/0052 →